← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2007Last known activity
Jun 11, 2024
Timeline
2000s
- Jun 1, 2006
Cognitive Research Corporation— Founded
Drugs by trial phase (16 distinct, 24 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Ataxia
- Bipolar Disorder
- Cerebellar Ataxia
- Dementia
- Depression
- Depressive Disorder
- Disease
- Major Depressive Disorder
- Mood Disorders
- Motor Neuron Disease
- Nocturia
- Psychomotor Agitation
- Psychotic Disorders
- Renal Insufficiency
- Schizophrenia
- Sclerosis
- Spinocerebellar Ataxias
- Spinocerebellar Degenerations
- Substance Withdrawal Syndrome
Recent trials (24)
- NCT06216132CollaboratorPhase 1Jun 11, 2024
- NCT06245213CollaboratorPhase 2Mar 15, 2024
- NCT05665088CollaboratorPhase 3Dec 14, 2022
- NCT05271552CollaboratorPhase 3Apr 27, 2022
- NCT05276830CollaboratorPhase 2Feb 8, 2022
- NCT05071430CollaboratorPhase 2Oct 6, 2021
- NCT05025605CollaboratorPhase 1Aug 27, 2021
- NCT04970342CollaboratorPhase 1Jul 16, 2021
- NCT03564548CollaboratorPhase 2May 26, 2021
- NCT05313386CollaboratorPhase 2Feb 23, 2021
- NCT04470050CollaboratorPhase 1/Phase 2Jun 12, 2020
- NCT04276883CollaboratorPhase 3Feb 18, 2020
- NCT04268303CollaboratorPhase 3Jan 24, 2020
- NCT04251910CollaboratorPhase 1/Phase 2Dec 27, 2019
- NCT04158687CollaboratorPhase 2Nov 26, 2019
Details
- Founded
- St Petersburg, FL, US Jun 1, 2006
- Last known activity
- Jun 11, 2024
Notes
CRO